ALBANY, N.Y., May 23, 2016 /PRNewswire/ -- Albany
Molecular Research Inc. (NASDAQ: AMRI) announced today that
William S. Marth, AMRI's President
and Chief Executive Officer, will present at Jefferies 2016
Healthcare Conference on Tuesday, June 7,
2016 at 3:30 p.m. ET. A live
audio webcast of the presentation can be accessed at AMRI's
Investor Relations web site at
http://ir.amriglobal.com/events.cfm?CalendarID=2
The webcast will be archived for 90 days following the live
presentation.
About AMRI
Albany Molecular Research Inc. (AMRI) is a global contract
research and manufacturing organization that has been working with
the Life Sciences industry to improve patient outcomes and the
quality of life for more than two decades. With locations
in North America, Europe and
Asia, our key business segments
include Discovery and Development Services (DDS), Active
Pharmaceutical Ingredients (API), and Drug Product Manufacturing
(DPM). Our DDS segment provides comprehensive services from hit
identification to IND, including expertise with diverse chemistry,
library design and synthesis, in vitro biology and pharmacology,
drug metabolism and pharmacokinetics, as well as natural products.
API supports the chemical development and cGMP manufacture of
complex API, including potent and cytotoxic compounds, controlled
substances, steroids, hormones, and sterile API. DPM supports
development through commercial scale production of complex
liquid-filled and lyophilized parenterals, sterile suspensions and
ophthalmic formulations. For more information about AMRI, please
visit our website at www.amriglobal.com or follow us on Twitter
(@amriglobal).
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/amri-ceo-to-present-at-jefferies-2016-healthcare-conference-300272252.html
SOURCE AMRI